Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 1Phase 1/2 1

Status

Active not recruiting 3Recruiting 1

Sponsor Class

INDUSTRY 2NIH 1NETWORK 1

Study Type

Interventional 4

Sponsor

Cancer Type

Head & Neck 4Gastrointestinal 2Thoracic 1Gynecologic 1Dermatologic 1

Conditions

Colorectal Neoplasms 24Stomach Neoplasms 10Pancreatic Neoplasms 10Rectal Neoplasms 9Colonic Neoplasms 9Adenocarcinoma Of Esophagus 8Esophageal Neoplasms 7Urinary Bladder Neoplasms 6Neoplasms 5Neoplasm Metastasis 5Carcinoma, Non-Small-Cell Lung 5Adenocarcinoma 5Squamous Cell Carcinoma of Head and Neck 4Parkinson Disease 4, Autosomal Dominant Lewy Body 4Cholangiocarcinoma 4Esophageal Squamous Cell Carcinoma 3Endometrial Neoplasms 3Carcinoma, Hepatocellular 3Carcinoma 3Ovarian Neoplasms 2Melanoma 2Lung Neoplasms 2Hepatoblastoma 2Gallbladder Neoplasms 2Biliary Tract Neoplasms 2Anus Neoplasms 2Advanced Solid Tumors 2Uterine Cervical Neoplasms 1Urothelial Carcinoma of the Bladder 1Urologic Neoplasms 1

Interventions

pembrolizumab 33Cisplatin 22Carboplatin 16Magnetic Resonance Spectroscopy 15Specimen Handling 12Cetuximab 12Radiotherapy, Intensity-Modulated 11Paclitaxel 9Platinum 8Nivolumab 81,2-diaminocyclohexaneplatinum II citrate 8atezolizumab 5Taxes 5Radiotherapy 5Docetaxel 5Biopsy 5Fluorouracil 4(225)Ac-DOTA-c(RGDyK) 4dostarlimab 3cemiplimab 3Radiotherapy, Image-Guided 3Radiation 3Fulvestrant 3Bevacizumab 3tislelizumab 2dehydroftorafur 2budigalimab 2amivantamab 2abemaciclib 2Tiragolumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Squamous Cell Carcinoma of Head and Neck × Fluorouracil × 30 days × Clear all
NCT00588770 2026-05-26

Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

National Cancer Institute (NCI)

Phase 3 Active not recruiting
403 enrolled 10 charts
Head & Neck

Lymphoid Interstitial Pneumonia, Squamous Cell Carcinoma of Head and Neck, Salivary Gland Neoplasms, Tongue Neoplasms

NCT06535607 2026-05-26

eVOLVE-02

AstraZeneca

Phase 2 Recruiting
257 enrolled
GastrointestinalGynecologicHead & Neck

Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma, Uterine Cervical Neoplasms

NCT04083599 2026-05-06

GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors

Genmab

Phase 1/2 Active not recruiting
350 enrolled
DermatologicGastrointestinalHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Melanoma, Colorectal Neoplasms

NCT05721755 2026-05-05

Combining Radiation Therapy With Immunotherapy for the Treatment of Metastatic Squamous Cell Carcinoma of the Head and Neck

Eastern Cooperative Oncology Group

Phase 3 Active not recruiting
290 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡